AVXL 8.63 (+1.89%)
US0327973006BiotechnologyBiotechnology

Anavex Life Sciences (AVXL) Stock Highlights

8.63 | +1.89%
2024-12-21 04:53:46
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are used to select patients that will receive the therapeutic benefit for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound ANAVEX 2-73 is being developed to treat Alzheimers disease, Parkinsons disease, and potentially other central nervous system diseases, including rare diseases, such as Rett syndrome, a rare severe neurological monogenic disorder caused by mutations in the X-linked gene, methyl-CpG-binding protein 2.

Statistics

Range Today
8.26 8.78
Volume Today 2.51M
Range 1 Year
3.25 10.45
Volume 1 Year 307.94M
Range 3 Year
3.25 20
Volume 3 Year 883.26M
Range 10 Year
0.628 31.5
Volume 10 Year 2.62B

Highlights

Market Capitalization 783.51M (small)
Floating Shares 82.21M
Current Price 8.63
Price To Earnings -12.29
Price To Book 6.04
Earnings Per Share -0.62
Payout Ratio 0%

Performance

Latest +1.89%
1 Month +4.23%
3 Months +50.87%
6 Months +124.16%
1 Year -13.27%
3 Years -51.46%
5 Years +258.09%
10 Years +1139.94%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.